Companies / Checkmate Pharmaceuticals, Inc.
Checkmate Pharmaceuticals, Inc.
CMPICIK 1651431
Activity
InsidersInstitutions
What the company's own insiders are buying and selling.| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Apr 19, 2022 | venBio Global Strategic Fund II L.P. 10% owner | Sell Open-market sale | Common Stock | $4.17M | -400K -10.89% | 3,273,451 | medium |
| May 2, 2022 | venBio Global Strategic Fund II L.P. 10% owner | Sell Open-market sale | Common Stock | $1.60M | -154K -5.48% | 2,652,133 | medium |
| May 12, 2022 | venBio Global Strategic Fund II L.P. 10% owner | Sell Open-market sale | Common Stock | $1.29M | -125K -5.16% | 2,287,580 | medium |
| May 16, 2022 | venBio Global Strategic Fund II L.P. 10% owner | Sell Open-market sale | Common Stock | $1.00M | -96K -4.25% | 2,155,930 | medium |
| Apr 20, 2022 | venBio Global Strategic Fund II L.P. 10% owner | Sell Open-market sale | Common Stock | $889.4K | -86K -2.62% | 3,187,840 | medium |
| May 3, 2022 | venBio Global Strategic Fund II L.P. 10% owner | Sell Open-market sale | Common Stock | $824.4K | -79K -3.00% | 2,572,658 | medium |
| Apr 28, 2022 | venBio Global Strategic Fund II L.P. 10% owner | Sell Open-market sale | Common Stock | $761.9K | -73K -2.49% | 2,875,063 | medium |
| Apr 29, 2022 | venBio Global Strategic Fund II L.P. 10% owner | Sell Open-market sale | Common Stock | $718.7K | -69K -2.41% | 2,805,833 | medium |